Suppr超能文献

多基因风险评分用于冠心病一级预防的健康经济分析——一个系统动力学模型

Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model.

作者信息

Vernon Stephen T, Brentnall Stuart, Currie Danielle J, Peng Cindy, Gray Michael P, Botta Giordano, Mujwara Deo, Nicholls Stephen J, Grieve Stuart M, Redfern Julie, Chow Clara, Levesque Jean-Frederic, Meikle Peter J, Jennings Garry, Ademi Zanfina, Wilson Andrew, Figtree Gemma A

机构信息

Cardiovascular Discovery Group, Kolling Institute of Medical Research, University of Sydney, Australia.

Department of Cardiology, Royal North Shore Hospital, Australia.

出版信息

Am J Prev Cardiol. 2024 May 18;18:100672. doi: 10.1016/j.ajpc.2024.100672. eCollection 2024 Jun.

Abstract

BACKGROUND

Primary prevention programs utilising traditional risk scores fail to identify all individuals who suffer acute cardiovascular events. We aimed to model the impact and cost effectiveness of incorporating a Polygenic risk scores (PRS) into the cardiovascular disease CVD primary prevention program in Australia, using a whole-of-system model.

METHODS

System dynamics models, encompassing acute and chronic CVD care in the Australian healthcare setting, assessing the cost-effectiveness of incorporating a CAD-PRS in the primary prevention setting. The time horizon was 10-years.

RESULTS

Pragmatically incorporating a CAD-PRS in the Australian primary prevention setting in middle-aged individuals already attending a Heart Health Check (HHC) who are determined to be at low or moderate risk based on the 5-year Framingham risk score (FRS), with conservative assumptions regarding uptake of PRS, could have prevented 2, 052 deaths over 10-years, and resulted in 24, 085 QALYs gained at a cost of $19, 945 per QALY with a net benefit of $724 million. If all Australians overs the age of 35 years old had their FRS and PRS performed, and acted upon, 12, 374 deaths and 60, 284 acute coronary events would be prevented, with 183, 682 QALYs gained at a cost of $18, 531 per QALY, with a net benefit of $5, 780 million.

CONCLUSIONS

Incorporating a CAD-PRS in a contemporary primary prevention setting in Australia would result in substantial health and societal benefits and is cost-effective. The broader the uptake of CAD-PRS in the primary prevention setting in middle-aged Australians, the greater the impact and the more cost-effective the strategy.

摘要

背景

利用传统风险评分的一级预防项目无法识别所有发生急性心血管事件的个体。我们旨在使用全系统模型,模拟将多基因风险评分(PRS)纳入澳大利亚心血管疾病(CVD)一级预防项目的影响和成本效益。

方法

系统动力学模型涵盖澳大利亚医疗环境中的急性和慢性CVD护理,评估在一级预防环境中纳入CAD-PRS的成本效益。时间跨度为10年。

结果

在澳大利亚,对于已参加心脏健康检查(HHC)且根据5年弗雷明汉风险评分(FRS)被确定为低风险或中度风险的中年个体,在一级预防环境中实际纳入CAD-PRS,并对PRS的接受情况做出保守假设,在10年内可预防2052例死亡,获得24085个质量调整生命年(QALY),每QALY成本为19945美元,净效益为7.24亿美元。如果所有35岁以上的澳大利亚人都进行FRS和PRS检测并据此采取行动,将可预防12374例死亡和60284例急性冠状动脉事件,获得183682个QALY,每QALY成本为18531美元,净效益为57.8亿美元。

结论

在澳大利亚当代一级预防环境中纳入CAD-PRS将带来巨大的健康和社会效益,且具有成本效益。在澳大利亚中年人的一级预防环境中,CAD-PRS的接受范围越广,该策略的影响就越大,成本效益也就越高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/11143886/228661d882ca/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验